Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer is a phase 2, interventional study registered as NCT07297004 by Sixth Affiliated Hospital, Sun Yat-sen University, with a registry enrolment figure of 20 participants, started 2025-01-01 and due to reach its primary completion in 2026-11-30. Interventions recorded: Stereotactic Body Radiation Therapy (SBRT). Conditions listed: Unresectable Locally Recurrent Rectal Cancer. Primary outcome: 1-year local progression-free survival (LPFS). Colorectal eligibility wording from the registry: "No clear distant metastasis at the time of diagnosis of locally recurrent rectal adenocarcinoma or MDT assesses that oligometastatic lesions are resectable or controlable (UICC 8th edition);". Sites: China. No results are recorded here; the registry entry is the source.